Gilead Sciences (GILD) Ratios
Gilead Sciences Ratios
MX:GILD's free cash flow for Q3 2026 was $4.80B. For the 2026 fiscal year, MX:GILD's free cash flow was decreased by $-237.00M and operating cash flow was $5.04B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.55 | 1.60 | 1.43 | 1.29 | 1.27 |
| Quick Ratio | 1.40 | 1.45 | 1.27 | 1.15 | 1.13 |
| Cash Ratio | 0.64 | 0.83 | 0.54 | 0.48 | 0.46 |
| Solvency Ratio | 0.31 | 0.08 | 0.21 | 0.16 | 0.18 |
| Operating Cash Flow Ratio | 0.85 | 0.90 | 0.71 | 0.81 | 0.98 |
| Short-Term Operating Cash Flow Coverage | 3.57 | 5.97 | 4.45 | 3.99 | 7.51 |
| Net Current Asset Value | $ -18.06B | $ -20.58B | $ -23.29B | $ -27.52B | $ -32.12B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.42 | 0.45 | 0.40 | 0.40 | 0.39 |
| Debt-to-Equity Ratio | 1.10 | 1.38 | 1.09 | 1.19 | 1.27 |
| Debt-to-Capital Ratio | 0.52 | 0.58 | 0.52 | 0.54 | 0.56 |
| Long-Term Debt-to-Capital Ratio | 0.49 | 0.56 | 0.50 | 0.52 | 0.54 |
| Financial Leverage Ratio | 2.60 | 3.05 | 2.72 | 2.97 | 3.23 |
| Debt Service Coverage Ratio | 3.21 | 1.51 | 3.37 | 2.37 | 3.68 |
| Interest Coverage Ratio | 11.43 | 1.70 | 8.06 | 7.84 | 9.91 |
| Debt to Market Cap | 0.16 | 0.23 | 0.25 | 0.23 | 0.29 |
| Interest Debt Per Share | 20.87 | 22.20 | 20.78 | 20.85 | 22.05 |
| Net Debt to EBITDA | 1.28 | 3.77 | 1.80 | 2.24 | 1.89 |
| Profitability Margins | |||||
| Gross Profit Margin | 78.83% | 78.26% | 76.04% | 79.26% | 75.82% |
| EBIT Margin | 36.75% | 5.80% | 28.78% | 24.74% | 33.98% |
| EBITDA Margin | 46.12% | 15.42% | 38.71% | 32.45% | 41.49% |
| Operating Profit Margin | 39.74% | 5.78% | 28.05% | 26.87% | 36.32% |
| Pretax Profit Margin | 33.27% | 2.40% | 25.30% | 21.31% | 30.32% |
| Net Profit Margin | 28.90% | 1.67% | 20.89% | 16.83% | 22.80% |
| Continuous Operations Profit Margin | 28.90% | 1.67% | 20.70% | 16.74% | 22.71% |
| Net Income Per EBT | 86.87% | 69.57% | 82.59% | 78.98% | 75.20% |
| EBT Per EBIT | 83.72% | 41.52% | 90.19% | 79.32% | 83.46% |
| Return on Assets (ROA) | 14.42% | 0.81% | 9.12% | 7.27% | 9.16% |
| Return on Equity (ROE) | 37.49% | 2.48% | 24.81% | 21.62% | 29.55% |
| Return on Capital Employed (ROCE) | 24.79% | 3.54% | 14.96% | 14.11% | 17.60% |
| Return on Invested Capital (ROIC) | 20.32% | 2.36% | 11.82% | 10.62% | 12.84% |
| Return on Tangible Assets | 25.23% | 1.56% | 20.71% | 17.69% | 23.79% |
| Earnings Yield | 5.57% | 0.42% | 5.60% | 4.26% | 6.83% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.99 | 6.51 | 5.82 | 5.71 | 6.08 |
| Payables Turnover | 8.72 | 7.50 | 11.81 | 6.25 | 9.36 |
| Inventory Turnover | 3.51 | 3.66 | 3.64 | 3.75 | 4.08 |
| Fixed Asset Turnover | 5.25 | 5.31 | 5.10 | 4.98 | 5.33 |
| Asset Turnover | 0.50 | 0.49 | 0.44 | 0.43 | 0.40 |
| Working Capital Turnover Ratio | 4.30 | 4.80 | 6.77 | 8.57 | 7.04 |
| Cash Conversion Cycle | 122.91 | 107.32 | 132.21 | 102.75 | 110.54 |
| Days of Sales Outstanding | 60.91 | 56.11 | 62.73 | 63.91 | 60.06 |
| Days of Inventory Outstanding | 103.87 | 99.85 | 100.38 | 97.23 | 89.47 |
| Days of Payables Outstanding | 41.86 | 48.64 | 30.89 | 58.39 | 38.98 |
| Operating Cycle | 164.78 | 155.96 | 163.10 | 161.15 | 149.53 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 8.05 | 8.68 | 6.42 | 7.23 | 9.06 |
| Free Cash Flow Per Share | 7.60 | 8.26 | 5.95 | 6.65 | 8.60 |
| Dividend Paid and CapEx Coverage Ratio | 2.19 | 2.44 | 1.82 | 2.04 | 2.72 |
| Capital Expenditure Coverage Ratio | 17.80 | 20.70 | 13.69 | 12.46 | 19.66 |
| Operating Cash Flow Coverage Ratio | 0.40 | 0.41 | 0.32 | 0.36 | 0.43 |
| Operating Cash Flow to Sales Ratio | 0.34 | 0.38 | 0.30 | 0.33 | 0.42 |
| Free Cash Flow Yield | 6.19% | 8.95% | 7.34% | 7.74% | 11.85% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 17.94 | 243.08 | 17.85 | 23.46 | 14.65 |
| Price-to-Sales (P/S) Ratio | 5.19 | 4.01 | 3.73 | 3.95 | 3.34 |
| Price-to-Book (P/B) Ratio | 6.73 | 5.96 | 4.43 | 5.07 | 4.33 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 16.15 | 11.18 | 13.62 | 12.91 | 8.44 |
| Price-to-Operating Cash Flow Ratio | 15.24 | 10.64 | 12.63 | 11.88 | 8.01 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -2.65 | 0.74 | -0.90 | 0.00 |
| Enterprise Value Multiple | 12.52 | 29.75 | 11.43 | 14.41 | 9.94 |
| Enterprise Value | 170.06B | 131.91B | 120.00B | 127.56B | 112.56B |
| EV to EBITDA | 12.52 | 29.75 | 11.43 | 14.41 | 9.94 |
| EV to Sales | 5.78 | 4.59 | 4.43 | 4.68 | 4.12 |
| EV to Free Cash Flow | 17.98 | 12.80 | 16.17 | 15.29 | 10.42 |
| EV to Operating Cash Flow | 16.97 | 12.18 | 14.99 | 14.06 | 9.89 |
| Tangible Book Value Per Share | -2.15 | -7.23 | -9.63 | -12.75 | -16.50 |
| Shareholders’ Equity Per Share | 18.25 | 15.50 | 18.30 | 16.92 | 16.77 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.13 | 0.31 | 0.18 | 0.21 | 0.25 |
| Revenue Per Share | 23.67 | 23.06 | 21.73 | 21.74 | 21.74 |
| Net Income Per Share | 6.84 | 0.38 | 4.54 | 3.66 | 4.96 |
| Tax Burden | 0.87 | 0.70 | 0.83 | 0.79 | 0.75 |
| Interest Burden | 0.91 | 0.41 | 0.88 | 0.86 | 0.89 |
| Research & Development to Revenue | 0.20 | 0.21 | 0.21 | 0.18 | 0.17 |
| SG&A to Revenue | 0.19 | 0.21 | 0.10 | 0.18 | 0.17 |
| Stock-Based Compensation to Revenue | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 |
| Income Quality | 1.18 | 22.56 | 1.41 | 1.98 | 1.84 |
Currency in USD